Salbutamol Enrolling by Invitation Phase 3 Trials for Asthma, Allergic Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03468790Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.